Stage IIIC Prostate Cancer AJCC v8 Not Yet Recruiting Phase 3 Trials for Abiraterone (DB05812)

IndicationStatusPhase
DBCOND0109672 (Stage IIIC Prostate Cancer AJCC v8)Not Yet Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs